Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Collaborative clinical trials: quality or quantity?

I F Tannock1

  • 1Department of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. ian.tannock@uhn.on.ca

International Journal of Radiation Oncology, Biology, Physics
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy.

British journal of cancer·2024
Same author

Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Rules for the conduct of clinical trials need revision, but 'good clinical practice' requires much more.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Improving access to immunotherapy in low- and middle-income countries.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Have investigators forgotten how to write?

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Clinical trial design must optimize resource allocation. Non-randomized and small randomized trials often waste resources, while large trials for common tumors and hypothesis-driven small trials focusing on tumor heterogeneity are more effective.

Area of Science:

  • Oncology
  • Clinical Trial Design
  • Biostatistics

Background:

  • Limited resources necessitate careful consideration in clinical trial design.
  • Evaluating the efficiency of various clinical trial types is crucial for advancing cancer research.

Discussion:

  • Non-randomized trials lacking mechanistic insights and small randomized trials with interpretation challenges represent poor resource utilization.
  • Large trials are effective for detecting minor survival differences in common tumors, but not for transient palliative therapy improvements.

Key Insights:

  • Optimizing resource allocation in clinical trials is paramount.
  • Biologically-driven, mechanistic small trials are essential for identifying therapeutic index gains.
  • Recognizing tumor heterogeneity is key for developing effective, individualized treatment strategies.

Related Experiment Videos

Outlook:

  • Future research should focus on hypothesis-driven, mechanistic trials to uncover novel therapeutic strategies.
  • Individualized treatment strategies require rigorous evaluation against current standards of care.